# Cannabinoid Modulation of Pain

> **NCT01595620** · EARLY_PHASE1 · COMPLETED · sponsor: **Yale University** · enrollment: 6 (actual)

## Conditions studied

- Pain

## Interventions

- **OTHER:** Thermal
- **OTHER:** Electrical
- **OTHER:** Capsaicin
- **DRUG:** THC
- **DRUG:** THC
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01595620
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11-09
- **Primary completion:** 2012-04-19
- **Final completion:** 2012-04-19
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2022-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01595620

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01595620, "Cannabinoid Modulation of Pain". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01595620. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*